Literature DB >> 15005762

Fatty acids in colostrum from mothers of children at high risk of atopy in relation to clinical and laboratory signs of allergy in the first year of life.

P Reichardt1, D Müller, U Posselt, B Vorberg, U Diez, U Schlink, W Reuter, M Borte.   

Abstract

BACKGROUND: It remains controversial whether fatty acid (FA) composition of breast milk relates to development of atopy in the infant. This study evaluates FA in colostrum from mothers of children at high risk of atopy in association with atopy at the age of 1 year.
METHODS: The FA of colostrum were analyzed for 218 children (60 with low birth weight between 1500 and 2500 g, 84 with a history of maternal atopy, and 74 with an elevated cord blood immunoglobulin (Ig)E of >0.9 IU/ml). Total lipids were extracted, methylated and separated by gas-liquid chromatography. Laboratory screening for allergic sensitization and clinical examination took place within the Leipzig Allergy Risk Children's Study (LARS).
RESULTS: Low birth weight was correlated with low percentage levels of 20:2n-6, 22:2n-6, and 22:3n-3 (r = 0.14, P < 0.05; r = 0.14, P < 0.05 and r = 0.20, P < 0.01, respectively) and low gestational age at birth was correlated with low 22:3n-3 (r = 0.15, P < 0.05). There was no association between FA and atopic eczema at the age of 1 year. However, high linoleic acid (LA, 18:2n-6) was linked to high specific IgE against cow's milk protein (P < 0.05), and low docosapentaenoic acid (DPA, 22:5n-3) was associated with elevated total serum IgE (P < 0.05) at the age of 1 year, respectively.
CONCLUSIONS: The polyunsaturated fatty acid composition of colostrum in a high risk newborn population shows associations with atopic sensitization at the age of 1 year and may be predictive for later atopic disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15005762     DOI: 10.1111/j.1398-9995.2003.00429.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  8 in total

1.  Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2-year-old children.

Authors:  Lotte Lauritzen; Tanja M R Kjaer; Maj-Britt Fruekilde; Kim F Michaelsen; Hanne Frøkiaer
Journal:  Lipids       Date:  2005-07       Impact factor: 1.880

Review 2.  Maternal influences over offspring allergic responses.

Authors:  Joan M Cook-Mills
Journal:  Curr Allergy Asthma Rep       Date:  2015-02       Impact factor: 4.806

3.  Asthma and allergic diseases in pregnancy a review.

Authors:  Isabella Pali-Schöll; Cassim Motala; Erika Jensen-Jarolim
Journal:  World Allergy Organ J       Date:  2009-03       Impact factor: 4.084

Review 4.  They Are What You Eat: Can Nutritional Factors during Gestation and Early Infancy Modulate the Neonatal Immune Response?

Authors:  Sarah Prentice
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

Review 5.  Immunologically Active Components in Human Milk and Development of Atopic Disease, With Emphasis on Food Allergy, in the Pediatric Population.

Authors:  Puja S Rajani; Antti E Seppo; Kirsi M Järvinen
Journal:  Front Pediatr       Date:  2018-08-07       Impact factor: 3.418

6.  The causal association of polyunsaturated fatty acids with allergic disease: A two-sample Mendelian randomization study.

Authors:  Yajia Li; Qiangxiang Li; Ziqin Cao; Jianhuang Wu
Journal:  Front Nutr       Date:  2022-09-09

7.  β-Glucosylceramide From Allergic Mothers Enhances Offspring Responsiveness to Allergen.

Authors:  Matthew T Walker; Ryan P Ferrie; Aki Hoji; Lindsay M Schroeder-Carter; Jacob D Cohen; Ronald L Schnaar; Joan M Cook-Mills
Journal:  Front Allergy       Date:  2021-02-25

Review 8.  Perspective: Moving Toward Desirable Linoleic Acid Content in Infant Formula.

Authors:  Susan E Carlson; Lidewij Schipper; J Thomas Brenna; Carlo Agostoni; Philip C Calder; Stewart Forsyth; Philippe Legrand; Marieke Abrahamse-Berkeveld; Bert J M van de Heijning; Eline M van der Beek; Berthold V Koletzko; Beverly Muhlhausler
Journal:  Adv Nutr       Date:  2021-12-01       Impact factor: 8.701

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.